Related Experiment Video
Updated: May 21, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Interference of implanted cardiac pacemakers with TASER X26 dart mode application
Norbert Leitgeb1, Florian Niedermayr, Robert Neubauer
1Institute of Health Care Engineering with European Notified Body of Medical Devices, Graz University of Technology, Austria. norbert.leitgeb@tugraz.at
Cardiac pacemaker patients face potential risks from conducted energy devices. While interference voltages remain below safety thresholds, they can still affect pacemaker function, especially with abdominal implants.
Area of Science:
- Biomedical Engineering
- Electrophysiology
- Public Safety Technology
Background:
- Increasing prevalence of cardiac pacemakers and conducted energy devices (CEDs).
- Growing concern regarding the safety of pacemaker patients exposed to CEDs.
- Planned widespread use of CEDs in Europe necessitates risk assessment.
Purpose of the Study:
- To evaluate the risk to cardiac pacemaker patients from CEDs.
- To assess induced interference voltages in pacemakers due to CED use.
- To determine if pacemaker function can be affected by CEDs.
Main Methods:
- Numerical simulations using detailed anatomical models of pacemaker patients.
- Analysis of pacemakers implanted in left pectoral, right pectoral, and abdominal positions.
- Assessment of induced voltages from TASER X26 device application.
Main Results:
- Interference voltages were highest with abdominal pacemaker implantation.
- Pectoral implantation sites showed approximately 20% lower interference voltages.
- Induced voltages, though below immunity thresholds, were sufficient to potentially capture pacemaker function.
Conclusions:
- Cardiac pacemaker patients may be at risk from CEDs, particularly with abdominal implants.
- CED use could lead to pacemaker interference and altered function, even if not causing permanent damage.
- Further consideration of pacemaker patient safety is warranted with increasing CED prevalence.
More Related Videos
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Cardiopulmonary Resuscitation III: AED Use
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
